{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:25:06Z","timestamp":1793021106751,"version":"4.5.0"},"reference-count":188,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Juravinski Research Institute"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01AG080040-01A1"],"award-info":[{"award-number":["R01AG080040-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"award":["R01AG080040-01A1"],"award-info":[{"award-number":["R01AG080040-01A1"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Infectious complications remain a principal determinant of late morbidity and mortality following major thermal injury, reflecting a convergence of barrier disruption, microbial adaptation, and host immune dysfunction. The post-burn environment creates a uniquely permissive niche for pathogen persistence, characterized by altered tissue perfusion, biofilm formation, and dynamic shifts in microbial ecology toward multidrug-resistant organisms. Concurrently, profound and evolving changes in host immunity and metabolism reshape both susceptibility to infection and response to therapy. This review integrates current evidence across pathophysiology, microbiology, diagnostics, and treatment, with a focus on challenges that limit effective infection control in burn patients. Particular attention is given to diagnostic uncertainty arising from overlap between sterile inflammation and true infection, the clinical implications of biofilm-associated tolerance, and the impact of burn-specific pharmacokinetic variability on antimicrobial efficacy. We further examine emerging diagnostic and therapeutic innovations, including host-response profiling, rapid molecular detection platforms, and next-generation anti-infective strategies targeting microbial virulence, biofilm structure, and host immune pathways. Despite substantial scientific advances, translation into clinical practice remains constrained by limited burn-specific trials, heterogeneous definitions, and systemic barriers to antimicrobial development. Collectively, these challenges underscore the need for integrated, precision-based approaches that combine early source control, individualized antimicrobial optimization, and advanced diagnostic frameworks. Future progress will depend on coordinated efforts to standardize definitions, generate high-quality multicenter data, and align innovation with clinical applicability across diverse healthcare settings.<\/jats:p>","DOI":"10.3390\/antibiotics15040383","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:21:32Z","timestamp":1775737292000},"page":"383","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Burn Infections and Sepsis: Challenges and Future Prospects of Antibacterial Therapy"],"prefix":"10.3390","volume":"15","author":[{"given":"Ghazaleh","family":"Dadashizadeh","sequence":"first","affiliation":[{"name":"Department of Biochemistry and and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada"},{"name":"David Braley Research Institute, Hamilton, ON L8L 2X2, Canada"},{"name":"Center for Burn Research, Hamilton Health Sciences, Hamilton, ON L8P 1A2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-2236","authenticated-orcid":false,"given":"Margarita","family":"Elloso","sequence":"additional","affiliation":[{"name":"David Braley Research Institute, Hamilton, ON L8L 2X2, Canada"},{"name":"Center for Burn Research, Hamilton Health Sciences, Hamilton, ON L8P 1A2, Canada"},{"name":"Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Jeschke","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada"},{"name":"David Braley Research Institute, Hamilton, ON L8L 2X2, Canada"},{"name":"Center for Burn Research, Hamilton Health Sciences, Hamilton, ON L8P 1A2, Canada"},{"name":"Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"ref_1","unstructured":"(2026, March 04). Burns. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/burns."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Yakupu, A., Zhang, J., Dong, W., Song, F., Dong, J., and Lu, S. (2022). The epidemiological characteristic and trends of burns globally. BMC Public Health, 22.","DOI":"10.1186\/s12889-022-13887-2"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"tkab037","DOI":"10.1093\/burnst\/tkab037","article-title":"Burn injury prevention in low- and middle- income countries: Scoping systematic review","volume":"9","author":"Price","year":"2021","journal-title":"Burn. Trauma"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-020-0145-5","article-title":"Burn injury","volume":"6","author":"Jeschke","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41522-021-00243-2","article-title":"Burns and biofilms: Priority pathogens and in vivo models","volume":"7","author":"Maslova","year":"2021","journal-title":"npj Biofilm. Microbiomes"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e976","DOI":"10.1002\/ams2.976","article-title":"Systemic immune response of burns from the acute to chronic phase","volume":"11","author":"Osuka","year":"2024","journal-title":"Acute Med. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.surg.2023.11.035","article-title":"Sepsis in surgical patients: Burn sepsis","volume":"175","author":"Tejiram","year":"2024","journal-title":"Surgery"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/SAP.0000000000000896","article-title":"History and Advancement of Burn Treatments","volume":"78","author":"Liu","year":"2017","journal-title":"Ann. Plast. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Moins-Teisserenc, H., Cordeiro, D.J., Audigier, V., Ressaire, Q., Benyamina, M., Lambert, J., Maki, G., Homyrda, L., Toubert, A., and Legrand, M. (2021). Severe Altered Immune Status After Burn Injury Is Associated With Bacterial Infection and Septic Shock. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.586195"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"tkaa047","DOI":"10.1093\/burnst\/tkaa047","article-title":"The pathogenesis and diagnosis of sepsis post burn injury","volume":"9","author":"Zhang","year":"2021","journal-title":"Burn. Trauma"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s41038-017-0089-5","article-title":"Sepsis in the burn patient: A different problem than sepsis in the general population","volume":"5","author":"Greenhalgh","year":"2017","journal-title":"Burn. Trauma"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/CMR.19.2.403-434.2006","article-title":"Burn wound infections","volume":"19","author":"Church","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(14)60687-5","article-title":"The systemic immune response to trauma: An overview of pathophysiology and treatment","volume":"384","author":"Lord","year":"2014","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/SLA.0000000000002097","article-title":"Pathophysiological Response to Burn Injury in Adults","volume":"267","author":"Stanojcic","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1017\/ash.2025.10213","article-title":"A research agenda for burn infection prevention: Identifying knowledge gaps and prioritizing future directions","volume":"5","author":"Sopirala","year":"2025","journal-title":"Antimicrob. Steward. Healthc. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.15537\/smj.2020.7.25141","article-title":"Epidemiology of burn-related infections in the largest burn unit in Saudi Arabia","volume":"41","author":"Mater","year":"2020","journal-title":"Saudi Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.ajic.2016.07.027","article-title":"Timeline of health care-associated infections and pathogens after burn injuries","volume":"44","author":"Strassle","year":"2016","journal-title":"Am. J. Infect. Control."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/sur.2013.134","article-title":"Infection in Burns","volume":"17","author":"Norbury","year":"2016","journal-title":"Surg. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Azzopardi, E.A., Azzopardi, E., Camilleri, L., Villapalos, J., Boyce, D.E., Dziewulski, P., Dickson, W.A., and Whitaker, I.S. (2014). Gram negative wound infection in hospitalised adult burn patients--systematic review and metanalysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095042"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Macedo-Vi\u00f1as, M., and Lucas, A. (2023). Evolution of Microbial Flora Colonizing Burn Wounds during Hospitalization in Uruguay. Biomedicines, 11.","DOI":"10.3390\/biomedicines11112900"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8854311","DOI":"10.1155\/2023\/8854311","article-title":"Multidrug-Resistant Pathogens in Burn Wound, Prevention, Diagnosis, and Therapeutic Approaches (Conventional Antimicrobials and Nanoparticles)","volume":"2023","author":"Hemmati","year":"2023","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3201\/eid3103.241195","article-title":"Candida auris Outbreak and Epidemiologic Response in Burn Intensive Care Unit, Illinois, USA, 2021\u20132023","volume":"31","author":"Barbian","year":"2025","journal-title":"Emerg. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e001325","DOI":"10.1136\/tsaco-2023-001325","article-title":"Clinical impact of fungal colonization of burn wounds in patients hospitalized in the intensive care unit: A retrospective cohort study","volume":"9","author":"Gur","year":"2024","journal-title":"Trauma Surg. Acute Care Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Du, H., Bing, J., Hu, T., Ennis, C.L., Nobile, C.J., and Huang, G. (2020). Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008921"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"114769","DOI":"10.1016\/j.addr.2023.114769","article-title":"Burn wound infections microbiome and novel approaches using therapeutic microorganisms in burn wound infection control","volume":"196","author":"Maitz","year":"2023","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gong, Y., Peng, Y., Luo, X., Zhang, C., Shi, Y., Zhang, Y., Deng, J., Peng, Y., Luo, G., and Li, H. (2021). Different Infection Profiles and Antimicrobial Resistance Patterns Between Burn ICU and Common Wards. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.681731"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.burns.2019.05.014","article-title":"MRSA colonization and acquisition in the burn unit: A systematic review and meta-analysis","volume":"45","author":"Kalligeros","year":"2019","journal-title":"Burns"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100640","DOI":"10.1016\/j.drup.2019.07.002","article-title":"Antibiotic resistance in Pseudomonas aeruginosa\u2014Mechanisms, epidemiology and evolution","volume":"44","author":"Botelho","year":"2019","journal-title":"Drug. Resist. Updat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Moradali, M.F., Ghods, S., and Rehm, B.H.A. (2017). Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00039"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13627","DOI":"10.1038\/s41598-019-50003-8","article-title":"Formation of Pseudomonas aeruginosa Biofilms in Full-thickness Scald Burn Wounds in Rats","volume":"9","author":"Brandenburg","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/0300060517703573","article-title":"Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014","volume":"45","author":"Dou","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and Pathophysiological Overview of Acinetobacter Infections: A Century of Challenges","volume":"30","author":"Wong","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_37","first-page":"e42984","article-title":"Investigation of Acinetobacter baumannii Outbreak in a Burn Unit Revealed a Surprising Environmental Source","volume":"15","author":"Mada","year":"2023","journal-title":"Cureus"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and Bonomo, R.A. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-Lactams and \u03b2-Lactamase Inhibitors: An Overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"myaf059","DOI":"10.1093\/mmy\/myaf059","article-title":"Fungal infections in burn patients: The rise of Fusarium as the most prevalent in a burn center in Mexico City","volume":"63","year":"2025","journal-title":"Med. Mycol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/jbcr\/iraf047","article-title":"Invasive Fungal Infection Increases Mortality Risk After Burn Injury","volume":"46","author":"Frederick","year":"2025","journal-title":"J. Burn. Care Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e00029-17","DOI":"10.1128\/CMR.00029-17","article-title":"Candida auris: A Review of the Literature","volume":"31","author":"Taori","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chowdhary, A., Sharma, C., and Meis, J.F. (2017). Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006290"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/jbcr\/irac160","article-title":"Prevalence of Multidrug-Resistant Organism in ICU Burns Patients at Tertiary Care Hospital","volume":"44","author":"Buriro","year":"2023","journal-title":"J. Burn. Care Res."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Alharthi, A.F., Al Sulaiman, K., Alotaibi, S., Alqahtani, R., Damfu, N., Alharbi, A., Alomair, S., Alhaidal, H.A., and Aljuhani, O. (2025). Managing Infections in Burn Patients: Strategies and Considerations for Antimicrobial Dosing. Eur. Burn. J., 6.","DOI":"10.3390\/ebj6040053"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4266\/acc.2023.01571","article-title":"Microbial infections in burn patients","volume":"39","author":"Roy","year":"2024","journal-title":"Acute Crit. Care"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13756-016-0157-9","article-title":"Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: Contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission?","volume":"5","author":"Salm","year":"2016","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajic.2011.04.326","article-title":"Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital","volume":"40","author":"Baang","year":"2012","journal-title":"Am. J. Infect. Control."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Machado, E., and Sousa, J.C. (2025). New Antibiotics for Treating Infections Caused by Multidrug-Resistant Bacteria. Antibiotics, 14.","DOI":"10.3390\/antibiotics14100997"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/BCR.0000000000000256","article-title":"Multidrug-Resistant Bacterial Outbreaks in Burn Units: A Synthesis of the Literature According to the ORION Statement","volume":"37","author":"Vanhems","year":"2016","journal-title":"J. Burn. Care Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_53","first-page":"269","article-title":"Vancomycin Resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Giovagnorio, F., De Vito, A., Madeddu, G., Parisi, S.G., and Geremia, N. (2023). Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments. Antibiotics, 12.","DOI":"10.3390\/antibiotics12111621"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lorusso, A.B., Carrara, J.A., Barroso, C.D.N., Tuon, F.F., and Faoro, H. (2022). Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415779"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e00495-24","DOI":"10.1128\/spectrum.00495-24","article-title":"Outer membrane permeability of Pseudomonas aeruginosa through \u03b2-lactams: New evidence on the role of OprD and OpdP porins in antibiotic resistance","volume":"13","author":"Amisano","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e02079-25","DOI":"10.1128\/spectrum.02079-25","article-title":"Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020\u20132023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed \u03b2-lactam\/\u03b2-lactamase inhibitor combinations: Results from the SENTRY antimicrobial surveillance program","volume":"13","author":"Kimbrough","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/2049-632X.12125","article-title":"Acinetobacter baumannii: Evolution of a global pathogen","volume":"71","author":"Antunes","year":"2014","journal-title":"Pathog. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology","volume":"12","author":"Poirel","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9348199","DOI":"10.1155\/bmri\/9348199","article-title":"Biofilm Formation in Clinical Acinetobacter baumannii Is Influenced by Isolate Source and Is Inversely Correlated With Antibiotic Resistance","volume":"2026","author":"Ababneh","year":"2026","journal-title":"BioMed. Res. Int."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Aitken, S.L., Bonomo, R.A., Mathers, A.J., van Duin, D., and Clancy, C.J. (2023). Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin. Infect. Dis., ciad428.","DOI":"10.1093\/cid\/ciad428"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lee, C.-R., Lee, J.H., Park, M., Park, K.S., Bae, I.K., Kim, Y.B., Cha, C.-J., Jeong, B.C., and Lee, S.H. (2017). Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front. Cell. Infect. Microbiol., 7.","DOI":"10.3389\/fcimb.2017.00055"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Han, R., Shi, Q., Wu, S., Yin, D., Peng, M., Dong, D., Zheng, Y., Guo, Y., Zhang, R., and Hu, F. (2020). Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00314"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10096-022-04408-5","article-title":"Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era","volume":"41","author":"Bianco","year":"2022","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Karaiskos, I., Galani, I., Daikos, G.L., and Giamarellou, H. (2025). Breaking Through Resistance: A Comparative Review of New Beta-Lactamase Inhibitors (Avibactam, Vaborbactam, Relebactam) Against Multidrug-Resistant Superbugs. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050528"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e00078-23","DOI":"10.1128\/aac.00078-23","article-title":"Impact of Minor Carbapenemases on Susceptibility to Novel \u03b2-Lactam\/\u03b2-Lactamase Inhibitor Combinations and Cefiderocol in Enterobacterales","volume":"67","author":"Sadek","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e00047-19","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of \u03b2-Lactamase-Producing Pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","article-title":"Interplay between \u03b2-lactamases and new \u03b2-lactamase inhibitors","volume":"17","author":"Bush","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: Quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e00102-19","DOI":"10.1128\/CMR.00102-19","article-title":"The Global Ascendency of OXA-48-Type Carbapenemases","volume":"33","author":"Pitout","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Caliskan-Aydogan, O., and Alocilja, E.C. (2023). A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques. Microorganisms, 11.","DOI":"10.3390\/microorganisms11061491"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/cid\/ciz173","article-title":"Antibacterial Resistance Leadership Group A Primer on AmpC \u03b2-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World","volume":"69","author":"Tamma","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Tebano, G., Zaghi, I., Cricca, M., and Cristini, F. (2024). Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales. Pharmacy, 12.","DOI":"10.3390\/pharmacy12050142"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s15010-024-02447-y","article-title":"Piperacillin\/tazobactam vs. cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: A systematic review and meta-analysis","volume":"53","author":"Onorato","year":"2025","journal-title":"Infection"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"a019752","DOI":"10.1101\/cshperspect.a019752","article-title":"Mechanisms of Antifungal Drug Resistance","volume":"5","author":"Cowen","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.micinf.2016.01.002","article-title":"Candida albicans biofilms: Development, regulation, and molecular mechanisms","volume":"18","author":"Gulati","year":"2016","journal-title":"Microbes Infect."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Gabald\u00f3n, T., Garcia-Rubio, R., Jenks, J.D., Hoenigl, M., Salzer, H.J.F., Ilkit, M., Lass-Fl\u00f6rl, C., and Perlin, D.S. (2020). Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium. Antibiotics, 9.","DOI":"10.3390\/antibiotics9120877"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103243","DOI":"10.1016\/j.fgb.2019.103243","article-title":"Candida auris and multidrug resistance: Defining the new normal","volume":"131","author":"Lockhart","year":"2019","journal-title":"Fungal Genet. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e00458-19","DOI":"10.1128\/mSphere.00458-19","article-title":"Combined Antifungal Resistance and Biofilm Tolerance: The Global Threat of Candida auris","volume":"4","author":"Kean","year":"2019","journal-title":"mSphere"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris","volume":"6","author":"Cortegiani","year":"2018","journal-title":"J. Intensive Care"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.surg.2018.05.053","article-title":"Sepsis criteria versus clinical diagnosis of sepsis in burn patients: A validation of current sepsis scores","volume":"164","author":"Yan","year":"2018","journal-title":"Surgery"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/sur.2017.288","article-title":"Status and Challenges of Predicting and Diagnosing Sepsis in Burn Patients","volume":"19","author":"Stanojcic","year":"2018","journal-title":"Surg. Infect."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Thomas, R.E., and Thomas, B.C. (2021). Reducing Biofilm Infections in Burn Patients\u2019 Wounds and Biofilms on Surfaces in Hospitals, Medical Facilities and Medical Equipment to Improve Burn Care: A Systematic Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182413195"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.burns.2019.12.004","article-title":"Role of systemic antibiotic prophylaxis in acute burns: A retrospective analysis from a tertiary care center","volume":"46","author":"Muthukumar","year":"2020","journal-title":"Burns"},{"key":"ref_87","first-page":"188","article-title":"Antibiotic resistance in bacterial infections of burn wounds: Challenges, mortality, and solutions","volume":"1","author":"Moghadam","year":"2025","journal-title":"Iran. J. Burn. Wound Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/sur.2020.297","article-title":"Sepsis Definitions in Burns","volume":"22","author":"Rehou","year":"2021","journal-title":"Surg. Infect."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/ebj3010014","article-title":"Infection and Burn Injury","volume":"3","author":"Kelly","year":"2022","journal-title":"Eur. Burn. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/wound.2020.1330","article-title":"Cerium Nitrate Treatment in the Management of Burns","volume":"11","author":"Deldar","year":"2022","journal-title":"Adv. Wound Care"},{"key":"ref_91","unstructured":"Ritchie, J., Pomonis, J., and Westgate, S. (2023). Models and methods to support the development of novel burn wound antimicrobial treatments. Wounds UK, 19, Available online: https:\/\/wounds-uk.com\/journal-articles\/models-and-methods-to-support-the-development-of-novel-burn-wound-antimicrobial-treatments\/."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Almuhanna, Y. (2025). Microbial Biofilms as Barriers to Chronic Wound Healing: Diagnostic Challenges and Therapeutic Advances. J. Clin. Med., 14.","DOI":"10.3390\/jcm14228121"},{"key":"ref_94","unstructured":"(2026, March 04). Pharmacokinetics and Pharmacodynamics of Antimicrobial Agents in Burn Patients\u2014Kaitlin A. Pruskowski. Available online: https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/sur.2020.375."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et Th\u00e9rapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et R\u00e9animation-SFAR)","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit. Care"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Tebano, G., la Martire, G., Raumer, L., Cricca, M., Melandri, D., Pea, F., and Cristini, F. (2023). Which Are the Best Regimens of Broad-Spectrum Beta-Lactam Antibiotics in Burn Patients? A Systematic Review of Evidence from Pharmacology Studies. Antibiotics, 12.","DOI":"10.3390\/antibiotics12121737"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.clinthera.2017.06.008","article-title":"Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients","volume":"39","author":"Machado","year":"2017","journal-title":"Clin. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/cid\/ciac506","article-title":"Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis","volume":"75","author":"Ashok","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: An emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"a012427","DOI":"10.1101\/cshperspect.a012427","article-title":"Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control","volume":"2","author":"Rutherford","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41579-019-0186-5","article-title":"Bacterial quorum sensing in complex and dynamically changing environments","volume":"17","author":"Mukherjee","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Uru\u00e9n, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R.C., and Arenas, J. (2020). Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance. Antibiotics, 10.","DOI":"10.3390\/antibiotics10010003"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sharma, A., Katoch, P., and Shrivastava, R. (2026). Bacterial biofilm conundrum: Insight into the frontiers of antibiotic resistance and state-of-the-art anti-biofilm interventions. Front. Cell. Infect. Microbiol., 16.","DOI":"10.3389\/fcimb.2026.1589866"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Kunnath, A.P., Suodha Suoodh, M., Chellappan, D.K., Chellian, J., and Palaniveloo, K. (2024). Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update. Br. J. Biomed. Sci., 81.","DOI":"10.3389\/bjbs.2024.12958"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Mayer, P., Smith, A.C., Hurlow, J., Morrow, B.R., Bohn, G.A., and Bowler, P.G. (2024). Assessing Biofilm at the Bedside: Exploring Reliable Accessible Biofilm Detection Methods. Diagnostics, 14.","DOI":"10.3390\/diagnostics14192116"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Anju, V.T., Busi, S., Imchen, M., Kumavath, R., Mohan, M.S., Salim, S.A., Subhaswaraj, P., and Dyavaiah, M. (2022). Polymicrobial Infections and Biofilms: Clinical Significance and Eradication Strategies. Antibiotics, 11.","DOI":"10.3390\/antibiotics11121731"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s40001-023-01121-7","article-title":"Biofilm and wound healing: From bench to bedside","volume":"28","author":"Goswami","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"452","DOI":"10.12968\/jowc.2017.26.8.452","article-title":"Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: A clinical study","volume":"26","author":"Rennie","year":"2017","journal-title":"J. Wound Care"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Oropallo, A.R., Andersen, C., Abdo, R., Hurlow, J., Kelso, M., Melin, M., and Serena, T.E. (2021). Guidelines for Point-of-Care Fluorescence Imaging for Detection of Wound Bacterial Burden Based on Delphi Consensus. Diagnostics, 11.","DOI":"10.3390\/diagnostics11071219"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","article-title":"The prevalence of biofilms in chronic wounds: A systematic review and meta-analysis of published data","volume":"26","author":"Malone","year":"2017","journal-title":"J. Wound Care"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"275e","DOI":"10.1097\/PRS.0000000000008142","article-title":"Biofilm Management in Wound Care","volume":"148","author":"Sen","year":"2021","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1128\/AEM.69.8.4814-4822.2003","article-title":"N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces","volume":"69","author":"Olofsson","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s40265-019-01184-z","article-title":"Novel Treatment Strategies for Biofilm-Based Infections","volume":"79","author":"Vuotto","year":"2019","journal-title":"Drugs"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.WON.0000319125.21854.78","article-title":"Enzymatic wound debridement","volume":"35","author":"Ramundo","year":"2008","journal-title":"J. Wound Ostomy Cont. Nurs."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/jbcr\/iraa074","article-title":"Clinical Value of Debriding Enzymes as an Adjunct to Standard Early Surgical Excision in Human Burns: A Systematic Review","volume":"41","author":"Salehi","year":"2020","journal-title":"J. Burn. Care Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40257-025-00953-9","article-title":"What\u2019s New in Wound Healing: Treatment Advances and Microbial Insights","volume":"26","author":"Beraja","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.ento.45.1.55","article-title":"Medicinal maggots: An ancient remedy for some contemporary afflictions","volume":"45","author":"Sherman","year":"2000","journal-title":"Annu. Rev. Entomol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/jdv.13534","article-title":"Does maggot therapy promote wound healing? The clinical and cellular evidence","volume":"30","author":"Nigam","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Salisbury, A.-M., Mullin, M., Chen, R., and Percival, S.L. (2022). Antibiofilm Efficacy of Polihexanide, Octenidine and Sodium Hypochlorite\/Hypochlorous Acid Based Wound Irrigation Solutions against Staphylococcus aureus, Pseudomonas aeruginosa and a Multispecies Biofilm. Advances in Microbiology, Infectious Diseases and Public Health, Springer.","DOI":"10.1007\/5584_2021_645"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"tkac014","DOI":"10.1093\/burnst\/tkac014","article-title":"Challenges and innovations in treating chronic and acute wound infections: From basic science to clinical practice","volume":"10","author":"Ding","year":"2022","journal-title":"Burn. Trauma"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMra1807442","article-title":"Management of Burns","volume":"380","author":"Greenhalgh","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/sur.2020.368","article-title":"Topical Antimicrobial Agents for Burn Wound Care: History and Current Status","volume":"22","author":"Cancio","year":"2021","journal-title":"Surg. Infect."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14787210.2022.2044795","article-title":"Prevention and treatment of burn wound infections: The role of topical antimicrobials","volume":"20","author":"Ozhathil","year":"2022","journal-title":"Expert. Rev. Anti Infect. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Radzikowska-B\u00fcchner, E., \u0141opuszy\u0144ska, I., Flieger, W., Tobiasz, M., Maciejewski, R., and Flieger, J. (2023). An Overview of Recent Developments in the Management of Burn Injuries. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216357"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.52547\/wjps.11.3.3","article-title":"Topical Antimicrobial Agents for the Prevention of Burn-Wound Infection. What Do International Guidelines Recommend? A Systematic Review","volume":"11","year":"2022","journal-title":"World J. Plast. Surg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.burns.2021.05.014","article-title":"Efficacy and costs of nanocrystalline silver dressings versus 1% silver sulfadiazine dressings to treat burns in adults in the outpatient setting: A randomized clinical trial","volume":"48","author":"Moreira","year":"2022","journal-title":"Burns"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijsu.2017.06.073","article-title":"Povidone iodine in wound healing: A review of current concepts and practices","volume":"44","author":"Bigliardi","year":"2017","journal-title":"Int. J. Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/iwj.13537","article-title":"Update on the role of antiseptics in the management of chronic wounds with critical colonisation and\/or biofilm","volume":"18","author":"Alves","year":"2021","journal-title":"Int. Wound J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"tkad061","DOI":"10.1093\/burnst\/tkad061","article-title":"Consensus on the treatment of second-degree burn wounds (2024 edition)","volume":"12","author":"Ji","year":"2024","journal-title":"Burn. Trauma"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.burns.2020.04.004","article-title":"Comparison of the efficacy of silver-based antimicrobial burn dressings in a porcine model of burn wounds","volume":"46","author":"Ross","year":"2020","journal-title":"Burns"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/wound.2024.0129","article-title":"Local Treatment of Wound Infections: A Review of Clinical Trials from 2013 to 2024","volume":"14","author":"Larson","year":"2025","journal-title":"Adv. Wound Care"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"dlab060","DOI":"10.1093\/jacamr\/dlab060","article-title":"The antibiogram: Key considerations for its development and utilization","volume":"3","author":"Truong","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/14787210.2019.1648208","article-title":"Management and prevention of drug resistant infections in burn patients","volume":"17","author":"Vinaik","year":"2019","journal-title":"Expert. Rev. Anti-Infect. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00134-019-05871-z","article-title":"Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: No simple answers to simple questions-a viewpoint of experts","volume":"46","author":"Schouten","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_136","first-page":"311","article-title":"Evaluating the impact of de-escalating antimicrobial therapy in burn patients: A retrospective cohort study","volume":"77","author":"Kohama","year":"2022","journal-title":"Pharmazie"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jhin.2017.06.015","article-title":"Systemic antimicrobial prophylaxis in burn patients: Systematic review","volume":"97","author":"Ramos","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/BCR.0000000000000228","article-title":"Ventilator-Associated Pneumonia Prevention Bundle Significantly Reduces the Risk of Ventilator-Associated Pneumonia in Critically Ill Burn Patients","volume":"37","author":"Sen","year":"2016","journal-title":"J. Burn. Care Res."},{"key":"ref_139","unstructured":"CDC (2026, March 04). Intravascular Catheter-related Infection (BSI) Prevention Guidelines, Available online: https:\/\/www.cdc.gov\/infection-control\/hcp\/intravascular-catheter-related-infection\/index.html."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/ice.2022.88","article-title":"Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update","volume":"43","author":"Klompas","year":"2022","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/sur.2020.102","article-title":"Burn Infection and Burn Sepsis","volume":"22","author":"Shahrokhi","year":"2021","journal-title":"Surg. Infect."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/cid\/cix682","article-title":"Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance","volume":"65","author":"Lachiewicz","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Jarczak, D., Kluge, S., and Nierhaus, A. (2020). Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155543"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clinthera.2021.12.008","article-title":"Efficacy of Intravenous Immunoglobulin Therapy for Patients With Sepsis and Low Immunoglobulin G Levels: A Single-Center Retrospective Study","volume":"44","author":"Akatsuka","year":"2022","journal-title":"Clin. Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1742-481X.2012.01091.x","article-title":"Appropriate use of silver dressings in wounds: International consensus document","volume":"9","author":"Leaper","year":"2012","journal-title":"Int. Wound J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/iwj.13500","article-title":"Negative pressure wound therapy for burn patients: A meta-analysis and systematic review","volume":"18","author":"Lin","year":"2021","journal-title":"Int. Wound J."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e00954-17","DOI":"10.1128\/AAC.00954-17","article-title":"Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00192-025-06136-8","article-title":"Phage Therapy for Urinary Tract Infections: Progress and Challenges Ahead","volume":"36","author":"Morgan","year":"2025","journal-title":"Int. Urogynecol J."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.01028-06","article-title":"Phage Therapy of Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model","volume":"51","author":"McVay","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.copbio.2015.10.005","article-title":"Bacteriophage endolysins: Applications for food safety","volume":"37","author":"Schmelcher","year":"2016","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e02629-16","DOI":"10.1128\/AAC.02629-16","article-title":"Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers","volume":"61","author":"Jun","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00253-015-7247-0","article-title":"Bacteriophage-encoded depolymerases: Their diversity and biotechnological applications","volume":"100","author":"Pires","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Huan, Y., Kong, Q., Mou, H., and Yi, H. (2020). Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.582779"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","article-title":"The value of antimicrobial peptides in the age of resistance","volume":"20","author":"Magana","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Mahlapuu, M., H\u00e5kansson, J., Ringstad, L., and Bj\u00f6rn, C. (2016). Antimicrobial Peptides: An Emerging Category of Therapeutic Agents. Front. Cell. Infect. Microbiol., 6.","DOI":"10.3389\/fcimb.2016.00194"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Marciano, C.L., F\u00e9lix de Lima, J.V., do Couto Rosa, M.S., do Nascimento, R.A., Ferraz, A.d.O., da Silva, I.C., Chrysostomo-Massaro, T.N., da Rosa-Garzon, N.G., and Cabral, H. (2025). A Comprehensive Overview of Antimicrobial Peptides: Broad-Spectrum Activity, Computational Approaches, and Applications. Antibiotics, 14.","DOI":"10.20944\/preprints202510.0096.v1"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Adnan, S.B., Maarof, M., Fauzi, M.B., and Md Fadilah, N.I. (2025). Antimicrobial Peptides in Wound Healing and Skin Regeneration: Dual Roles in Immunity and Microbial Defense. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26135920"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","article-title":"Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges","volume":"23","author":"Zheng","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1038\/s41598-020-63464-z","article-title":"Delayed application of silver nanoparticles reveals the role of early inflammation in burn wound healing","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Khalil, M.A., El Maghraby, G.M., Sonbol, F.I., Allam, N.G., Ateya, P.S., and Ali, S.S. (2021). Enhanced Efficacy of Some Antibiotics in Presence of Silver Nanoparticles Against Multidrug Resistant Pseudomonas aeruginosa Recovered From Burn Wound Infections. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.648560"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"C29","DOI":"10.1152\/ajpcell.00080.2022","article-title":"Therapeutic potential of antimicrobial peptides for treatment of wound infection","volume":"324","author":"Haidari","year":"2023","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1109\/TNB.2016.2527600","article-title":"Nanoparticle-based Therapies for Wound Biofilm Infection: Opportunities and Challenges","volume":"15","author":"Kim","year":"2016","journal-title":"IEEE Trans. Nanobiosci."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bioorg.2014.04.005","article-title":"The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication","volume":"55","author":"Rampioni","year":"2014","journal-title":"Bioorg. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mib.2016.06.001","article-title":"Considerations and caveats in anti-virulence drug development","volume":"33","author":"Maura","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1099\/jmm.0.001134","article-title":"Harnessing bacterial interactions to manage infections: A review on the opportunistic pathogen Pseudomonas aeruginosa as a case example","volume":"69","author":"Rezzoagli","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: Antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.injury.2014.06.021","article-title":"The impact of trauma on neutrophil function","volume":"45","author":"Hazeldine","year":"2014","journal-title":"Injury"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","article-title":"A new antibiotic selectively kills Gram-negative pathogens","volume":"576","author":"Imai","year":"2019","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-020-1990-9","article-title":"Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling","volume":"578","author":"Culp","year":"2020","journal-title":"Nature"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","article-title":"A deep learning approach to antibiotic discovery","volume":"180","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0002-9343(84)90334-6","article-title":"Opportunistic infections in severely burned patients","volume":"76","author":"Pruitt","year":"1984","journal-title":"Am. J. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/ebj5030028","article-title":"Diagnosis and Treatment of Infections in the Burn Patient","volume":"5","author":"Greenhalgh","year":"2024","journal-title":"Eur. Burn. J."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/SHK.0b013e318237d6bf","article-title":"Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: A systematic review of the literature","volume":"37","author":"Mann","year":"2012","journal-title":"Shock"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.burns.2011.06.005","article-title":"Epidemiology of burns throughout the world. Part I: Distribution and risk factors","volume":"37","author":"Peck","year":"2011","journal-title":"Burns"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: A common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4248\/IJOS11026","article-title":"The clinical impact of bacterial biofilms","volume":"3","author":"Ciofu","year":"2011","journal-title":"Int. J. Oral. Sci."},{"key":"ref_180","first-page":"631","article-title":"A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy","volume":"29","author":"Cazzaniga","year":"2003","journal-title":"Dermatol. Surg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000658-198110000-00005","article-title":"Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury","volume":"194","author":"Burke","year":"1981","journal-title":"Ann. Surg."},{"key":"ref_182","first-page":"203","article-title":"Skin substitutes in burn care","volume":"20","author":"Paul","year":"2008","journal-title":"Wounds"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00005373-197012000-00001","article-title":"A new concept in the early excision and immediate grafting of burns","volume":"10","author":"Janzekovic","year":"1970","journal-title":"J. Trauma"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archsurg.1968.01330200022004","article-title":"Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns","volume":"96","author":"Fox","year":"1968","journal-title":"Arch. Surg."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Spronk, I., Legemate, C., Oen, I., van Loey, N., Polinder, S., and van Baar, M. (2018). Health related quality of life in adults after burn injuries: A systematic review. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0197507"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.burns.2016.07.004","article-title":"The effects of honey compared to silver sulfadiazine for the treatment of burns: A systematic review of randomized controlled trials","volume":"43","author":"Aziz","year":"2017","journal-title":"Burns"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.burns.2004.08.003","article-title":"Nursing Committee of the International Society for Burn Injuries Infection control in burn patients","volume":"30","author":"Weber","year":"2004","journal-title":"Burns"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11096-021-01358-4","article-title":"Antimicrobial stewardship for surgical antibiotic prophylaxis and surgical site infections: A systematic review","volume":"44","author":"Pereira","year":"2022","journal-title":"Int. J. Clin. Pharm."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/4\/383\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:51:48Z","timestamp":1775883108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/4\/383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":188,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["antibiotics15040383"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15040383","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}